Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols.

Attig S, Price L, Janetzki S, Kalos M, Pride M, McNeil L, Clay T, Yuan J, Odunsi K, Hoos A, Romero P, Britten CM; CRI-CIC Assay Working Group.

J Transl Med. 2011 Jul 11;9:108. doi: 10.1186/1479-5876-9-108.

2.

Multimer monitoring of CMV-specific T cells in research and in clinical applications.

Borchers S, Ogonek J, Varanasi PR, Tischer S, Bremm M, Eiz-Vesper B, Koehl U, Weissinger EM.

Diagn Microbiol Infect Dis. 2014 Mar;78(3):201-12. doi: 10.1016/j.diagmicrobio.2013.11.007. Epub 2013 Nov 15. Review.

PMID:
24331953
3.

Multimer technologies for detection and adoptive transfer of antigen-specific T cells.

Casalegno-Garduño R, Schmitt A, Yao J, Wang X, Xu X, Freund M, Schmitt M.

Cancer Immunol Immunother. 2010 Feb;59(2):195-202. doi: 10.1007/s00262-009-0778-4. Epub 2009 Oct 22. Review.

PMID:
19847424
4.

[MHC tetramers: tracking specific immunity].

Kosor E, Gagro A, Drazenović V, Kuzman I, Jeren T, Rakusić S, Rabatić S, Markotić A, Gotovac K, Sabioncello A, Cecuk E, Kerhin-Brkljacić V, Gjenero-Margan I, Kaić B, Mlinarić-Galinović G, Kastelan A, Dekaris D.

Acta Med Croatica. 2003;57(4):255-9. Review. Croatian.

PMID:
14639858
5.

The potential of multimer technologies in type 1 diabetes prediction strategies.

Fierabracci A.

Diabetes Metab Res Rev. 2011 Mar;27(3):216-29. doi: 10.1002/dmrr.1165. Review.

PMID:
21309048

Supplemental Content

Support Center